(Q40332582)

English

Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer

scientific article published on January 2010

Statements

Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer (English)
Hans-Joachim Stemmler
Isolde Gröll de Rivera
Wolfgang Abenhardt
Hans-Gerd Meerpohl
Marion Kiechle
Volker Heinemann

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit